Literature DB >> 17513092

Current issues in bipolar disorder: a critical review.

Pierre Oswald1, Daniel Souery, Siegfried Kasper, Yves Lecrubier, Stuart Montgomery, Sabien Wyckaert, Joseph Zohar, Julien Mendlewicz.   

Abstract

Although awareness on bipolar disorder has increased during the last decade, this condition remains characterized by a disabling burden, in terms of morbidity and functional impairment. This paper aims to review some critical issues in the current knowledge on Bipolar disorder. Although large European epidemiological studies are lacking, Bipolar disorder is characterized by a set of severe features, including an early age of onset, a chronic outcome and an important suicidal risk. A majority of bipolar patients also experience a comorbid Axis I condition, including substance abuse, anxiety disorder and attention-deficit hyperactivity disorder. This situation presents a therapeutic challenge, since antidepressants or methylphenidate may be associated with the risk of inducing mania. Recently, a large number of studies have provided evidence for the efficacy of new compounds in the treatment of both mania and bipolar depression, but also in long-term relapse prevention. Recent research has also allowed for the redefinition of the concept of mood stabilizer and for improving existing guidelines on the clinical management of Bipolar disorder.

Entities:  

Mesh:

Year:  2007        PMID: 17513092     DOI: 10.1016/j.euroneuro.2007.03.006

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  8 in total

1.  Cost effectiveness of quetiapine in patients with acute bipolar depression and in maintenance treatment after an acute depressive episode.

Authors:  Mattias Ekman; Peter Lindgren; Carolin Miltenburger; Genevieve Meier; Julie C Locklear; Mary Lou Chatterton
Journal:  Pharmacoeconomics       Date:  2012-06-01       Impact factor: 4.981

2.  Chronic Galphas signaling in the striatum increases anxiety-related behaviors independent of developmental effects.

Authors:  Christopher Favilla; Ted Abel; Michele P Kelly
Journal:  J Neurosci       Date:  2008-12-17       Impact factor: 6.167

3.  The societal cost of bipolar disorder in Sweden.

Authors:  Mattias Ekman; Ola Granström; Sead Omérov; Johanna Jacob; Mikael Landén
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2013-06-11       Impact factor: 4.328

4.  Evaluating depressive symptoms in mania: a naturalistic study of patients with bipolar disorder.

Authors:  Allan H Young; Jonas Eberhard
Journal:  Neuropsychiatr Dis Treat       Date:  2015-04-29       Impact factor: 2.570

Review 5.  Role of Hybrid Brain Imaging in Neuropsychiatric Disorders.

Authors:  Amer M Burhan; Nicole M Marlatt; Lena Palaniyappan; Udunna C Anazodo; Frank S Prato
Journal:  Diagnostics (Basel)       Date:  2015-12-04

6.  Specific alterations in plasma proteins during depressed, manic, and euthymic states of bipolar disorder.

Authors:  Y R Song; B Wu; Y T Yang; J Chen; L J Zhang; Z W Zhang; H Y Shi; C L Huang; J X Pan; P Xie
Journal:  Braz J Med Biol Res       Date:  2015-09-08       Impact factor: 2.590

7.  1H-NMR, 1H-NMR T2-edited, and 2D-NMR in bipolar disorder metabolic profiling.

Authors:  Sumit Sethi; Mariana Pedrini; Lucas B Rizzo; Maiara Zeni-Graiff; Caroline Dal Mas; Ana Cláudia Cassinelli; Mariane N Noto; Elson Asevedo; Quirino Cordeiro; João G M Pontes; Antonio J M Brasil; Acioly Lacerda; Mirian A F Hayashi; Ronei Poppi; Ljubica Tasic; Elisa Brietzke
Journal:  Int J Bipolar Disord       Date:  2017-06-04

8.  Co-morbidity in Bipolar Disorder: A Retrospective Study.

Authors:  Ravindra Neelakanthappa Munoli; Samir Kumar Praharaj; Podila Satya Venkata Narasimha Sharma
Journal:  Indian J Psychol Med       Date:  2014-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.